Peer-influenced content. Sources you trust. No registration required. This is HCN.

Addiction ProfessionalStudy Highlights Prevalence of Buprenorphine “Spiking” in Urine Screenings for OUD Patients

Originally published in JAMA Psychiatry, a broad-based study shows nearly 7% of OUD patients are adding buprenorphine to urine sample to fake treatment adherence. Buprenorphine spiking suggests to the physician that the treatment plan is not working—especially in patients continuing illicit drug use.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form